These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3036495)

  • 1. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.
    Androphy EJ; Hubbert NL; Schiller JT; Lowy DR
    EMBO J; 1987 Apr; 6(4):989-92. PubMed ID: 3036495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.
    Seedorf K; Oltersdorf T; Krämmer G; Röwekamp W
    EMBO J; 1987 Jan; 6(1):139-44. PubMed ID: 3034571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and genetic definition of a bovine papillomavirus type 1 E7 protein and absence of a low-copy-number phenotype exhibited by E5, E6, or E7 viral mutants.
    Jareborg N; Alderborn A; Burnett S
    J Virol; 1992 Aug; 66(8):4957-65. PubMed ID: 1321280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
    Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
    J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
    Park DS; Selvey LA; Kelsall SR; Frazer IH
    J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
    Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
    Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
    Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
    J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
    Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
    Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
    Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
    Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.